News about Global Pharma

Gland Pharma Granted USFDA Approval for Eribulin Mesylate Injection, Anticipates Market Launch

This approval marks a key moment for Gland Pharma as the product is anticipated to be the first generic approval on the market.

Global Pharma | 08/04/2024 | By Abha |  562

FDA Approves Expanded Indication for Abecma in Multiple Myeloma Treatment

Abecma, administered as a one-time infusion, demonstrates a progression-free survival benefit three times that of standard regimens in relapsed or refractory multiple myeloma.

Global Pharma | 08/04/2024 | By Abha |  679

Aurobindo Pharma Appoints T. Vijaya Kumar as President, R&D

Aurobindo Pharma has announced the appointment of T. Vijaya Kumar as President, R&D (Specialty Drug Delivery).

Global Pharma | 08/04/2024 | By Aishwarya |  1305

Cardio Diagnostics Enters Into Nationwide Telehealth Agreement with Navierre

This collaboration aims to significantly expand access to Cardio Diagnostics' industry-leading, AI-enabled precision cardiovascular diagnostic tests.

Global Pharma | 06/04/2024 | By Manvi |  525

Sebia Receives US FDA Clearance for CAPILLARYS 3 DBS Devices

This offer provides laboratories a gain in operational efficiency with high throughput and a full traceability from DBS card up to the result through a cyber-secured environment.

Global Pharma | 06/04/2024 | By Manvi |  545

Life Molecular Imaging and SOFIE Expand Partnership to Distribute Neuraceq PET Imaging Agent

Neuraceq® is an FDA-approved imaging agent used to detect beta-amyloid plaques in the brains of adult patients with cognitive impairment undergoing evaluation for Alzheimer's disease and other cognitive decline causes.

Global Pharma | 06/04/2024 | By Abha |  708

Johnson & Johnson Receives FDA Approval for CARVYKTI for Multiple Myeloma Treatment

With this advancement, CARVYKTI® becomes the first and only B-cell maturation antigen (BCMA)-targeted therapy approved for multiple myeloma treatment as early as the first relapse.

Global Pharma | 06/04/2024 | By Abha |  803

CDL Nuclear Technologies Introduces New Mobile Cardiac PET/CT Trailer

This cutting-edge mobile solution is designed to revolutionize cardiac care by directly providing state-of-the-art cardiac PET/CT imaging services to medical facilities on their schedule.

Global Pharma | 05/04/2024 | By Manvi |  479

NS Pharma Announces Research Alliance with MiNA Therapeutics to Develop Therapies for Rare Diseases of Central Nervous System

The agreement was facilitated by the NS Pharma Innovation Research Partnering (IRP) team, located in Cambridge, MA.

Global Pharma | 05/04/2024 | By Manvi |  378

Clario Acquires ArtiQ to Boost AI Use in Clinical Trials

Clario has recently acquired ArtiQ, an innovative software company dedicated to enhancing the diagnosis and monitoring of patients with respiratory conditions.

Global Pharma | 05/04/2024 | By Aishwarya |  852